Protein based nanoparticles for pulmonary drug delivery: advances, challenges, and future perspectives
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Inhalation and Respiratory Drug Delivery · Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Adel IM, Elmeligy MF, Abdelrahim MEA, et al (2021) Design and characterization of spray-dried proliposomes for the pulmonary delivery of curcumin. Int J Nanomedicine 16. https://doi.org/10.2147/IJN.S30683110.2147/IJN.S306831 ↗
2. Ahmad N, Pandey M, Mohamad N, et al (2020) Hydrogels for pulmonary drug delivery. In: Targeting chronic inflammatory lung diseases using advanced drug delivery systems10.1016/B978-0-12-820658-4.00021-2 ↗
3. Alsaab HO, Alharbi FD, Alhibs AS, et al (2022) PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases. Pharm 1410.3390/pharmaceutics14122728 ↗
4. Altammar KA (2023) A review on nanoparticles: characteristics, synthesis, applications, and challenges. Front Microbiol 1410.3389/fmicb.2023.1155622 ↗
5. Amini M, Kafshdouzsani MH, Akbari A, et al (2018) Spinel copper ferrite nanoparticles: preparation, characterization and catalytic activity. Appl Organomet Chem 32. https://doi.org/10.1002/aoc.447010.1002/aoc.4470 ↗
6. Ara N, Hafeez A (2024) Nanocarrier-mediated drug delivery via inhalational route for lung cancer therapy: a systematic and updated review. AAPS PharmSciTech 2510.1208/s12249-024-02758-1 ↗
7. Astete CE, Sabliov CM (2006) Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed 1710.1163/156856206775997322 ↗
8. A.Subodh U, Sandeep AC, Rupali SP, et al (2024) A comprehensive review on solid lipid nanoparticles. Asian J Pharm Res Dev 12. https://doi.org/10.22270/ajprd.v12i1.134810.22270/ajprd.v12i1.1348 ↗
9. Azuma Y, Tamiya M, Shiroyama T, et al (2015) Nanoparticle albumin-bound paclitaxel+carboplatin therapy for small cell lung cancer combined with squamous cell carcinoma and interstitial lung disease. Inter Med 54. https://doi.org/10.2169/internalmedicine.54.324310.2169/internalmedicine.54.3243 ↗
10. Bansil R, Turner BS (2006) Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci 1110.1016/j.cocis.2005.11.001 ↗
11. Beckman EJ (2004) Supercritical and near-critical CO2 in green chemical synthesis and processing. J Supercrit Fluids 28. https://doi.org/10.1016/S0896-8446(03)00029-910.1016/S0896-8446(03)00029-9 ↗
12. Bharatwaj B, Dimovski R, Conti DS, Da Rocha SRP (2014) Polymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, PNPs, and their nanoblends. AAPS J 16. https://doi.org/10.1208/s12248-014-9588-510.1208/s12248-014-9588-5 ↗
13. Bustos ARM, Encinar JR, Sanz-Medel A (2013) Mass spectrometry for the characterisation of nanoparticles. Anal Bioanal Chem 405. https://doi.org/10.1007/s00216-013-7014-y10.1007/s00216-013-7014-y ↗
14. Cadene A, Durand-Vidal S, Turq P, Brendle J (2005) Study of individual Na-montmorillonite particles size, morphology, and apparent charge. J Colloid Interface Sci 285. https://doi.org/10.1016/j.jcis.2004.12.01610.1016/j.jcis.2004.12.016 ↗
15. Chan HW, Chow S, Zhang X, et al (2023) Inhalable nanoparticle-based dry powder formulations for respiratory diseases: challenges and strategies for translational research. AAPS PharmSciTech 2410.1208/s12249-023-02559-y ↗
16. Chander S, Kulkarni GT, Dhiman N, Kharkwal H (2021) Protein-based nanohydrogels for bioactive delivery. Front Chem 910.3389/fchem.2021.573748 ↗
17. Chang RYK, Chow MYT, Khanal D, et al (2021) Dry powder pharmaceutical biologics for inhalation therapy. Adv Drug Deliv Rev 17210.1016/j.addr.2021.02.017 ↗
18. Chellappan DK, Prasher P, Saravanan V, et al (2022) Protein and peptide delivery to lungs by using advanced targeted drug delivery. Chem Biol Interact 35110.1016/j.cbi.2021.109706 ↗
19. Chen B, Yazdani B, Benedetti L, et al (2019) Fabrication of nanocomposite powders with a core-shell structure. Compos Sci Technol 170. https://doi.org/10.1016/j.compscitech.2018.11.04610.1016/j.compscitech.2018.11.046 ↗
20. Delvallée A, Feltin N, Ducourtieux S, et al (2015) Direct comparison of AFM and SEM measurements on the same set of nanoparticles. Meas Sci Technol 26. https://doi.org/10.1088/0957-0233/26/8/08560110.1088/0957-0233/26/8/085601 ↗
21. Deng Z, Kalin GT, Shi D, Kalinichenko VV (2021) Nanoparticle delivery systems with cell-specific targeting for pulmonary diseases. Am J Respir Cell Mol Biol 6410.1165/rcmb.2020-0306TR ↗
22. Dua K, Hansbro PM, Wadhwa R, et al (2020) Targeting chronic inflammatory lung diseases using advanced drug delivery systems
23. Dunn AW, Kalinichenko VV, Shi D (2018) Highly efficient in vivo targeting of the pulmonary endothelium using novel modifications of polyethylenimine: an importance of charge. Adv Healthc Mater 7. https://doi.org/10.1002/adhm.20180087610.1002/adhm.201800876 ↗
24. Elzoghby AO (2013) Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. J Contr Release 17210.1016/j.jconrel.2013.09.019 ↗
25. Elzoghby AO, Samy WM, Elgindy NA (2012) Protein-based nanocarriers as promising drug and gene delivery systems. J Contr Release 16110.1016/j.jconrel.2012.04.036 ↗
26. Emami F, Vatanara A, Park EJ, Na DH (2018) Drying technologies for the stability and bioavailability of biopharmaceuticals. Pharm 1010.3390/pharmaceutics10030131 ↗
27. Franks F (1998) Freeze-drying of bioproducts: putting principles into practice. Eur J Pharm Biopharm 4510.1016/S0939-6411(98)00004-6 ↗
28. Gatto MS, Najahi-Missaoui W (2023) Lyophilization of nanoparticles, does it really work? Overview of the current status and challenges. Int J Mol Sci 2410.3390/ijms241814041 ↗
29. GÖKMEŞE H, BOSTAN B, YİLMAZ TA, TASCİ U (2019) TEM characterization and synthesis of nanoparticle B4C by high-energy milling. Int Adv Res Eng J 3. https://doi.org/10.35860/iarej.63099910.35860/iarej.630999 ↗
30. Groneberg DA, Witt C, Wagner U, et al (2003) Fundamentals of pulmonary drug delivery. Respir Med 97. https://doi.org/10.1053/rmed.2002.145710.1053/rmed.2002.1457 ↗
31. Guerrero-Beltrán CE, Bernal-Ramírez J, Lozano O, et al (2017) Silica nanoparticles induce cardiotoxicity interfering with energetic status and Ca2+ handling in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol 312. https://doi.org/10.1152/ajpheart.00564.201610.1152/ajpheart.00564.2016 ↗
32. Guimarães D, Cavaco-Paulo A, Nogueira E (2021) Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm 60110.1016/j.ijpharm.2021.120571 ↗
33. Guo Y, Baldelli A, Singh A, et al (2022) Production of high loading insulin nanoparticles suitable for oral delivery by spray drying and freeze drying techniques. Sci Rep 12. https://doi.org/10.1038/s41598-022-13092-610.1038/s41598-022-13092-6 ↗
34. Hajebi S, Rabiee N, Bagherzadeh M, et al (2019) Stimulus-responsive polymeric nanogels as smart drug delivery systems. Acta Biomater 9210.2139/ssrn.3326753 ↗
35. Hernández-Giottonini KY, Rodríguez-Córdova RJ, Gutiérrez-Valenzuela CA, et al (2020) PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters. RSC Adv 1010.1039/C9RA10857B ↗
36. Hertel SP, Winter G, Friess W (2015) Protein stability in pulmonary drug delivery via nebulization. Adv Drug Deliv Rev 9310.1016/j.addr.2014.10.003 ↗
37. Ho DK, Nichols BLB, Edgar KJ, et al (2019) Challenges and strategies in drug delivery systems for treatment of pulmonary infections. Eur J Pharm Biopharm 14410.1016/j.ejpb.2019.09.002 ↗
38. Ho TC, Chang CC, Chan HP, et al (2022) Hydrogels: properties and applications in biomedicine. Mol 2710.3390/molecules27092902 ↗
39. Hong S, Choi DW, Kim HN, et al (2020) Protein-based nanoparticles as drug delivery systems. Pharm 1210.3390/pharmaceutics12070604 ↗
40. Huang Z, Kłodzińska SN, Wan F, Nielsen HM (2021) Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections. Drug Deliv Transl Res 11. https://doi.org/10.1007/s13346-021-00954-110.1007/s13346-021-00954-1 ↗
41. Huckaby JT, Lai SK (2018) PEGylation for enhancing nanoparticle diffusion in mucus. Adv Drug Deliv Rev 12410.1016/j.addr.2017.08.010 ↗
42. Jahanban-Esfahlan A, Dastmalchi S, Davaran S (2016) A simple improved desolvation method for the rapid preparation of albumin nanoparticles. Int J Biol Macromol 91. https://doi.org/10.1016/j.ijbiomac.2016.05.03210.1016/j.ijbiomac.2016.05.032 ↗
43. Jin Z, Gao Q, Wu K, et al (2023) Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy. Adv Drug Deliv Rev 20210.1016/j.addr.2023.115111 ↗
44. Joshi M, Misra AN (2001) Pulmonary disposition of budesonide from liposomal dry powder inhaler. Methods Find Exp Clin Pharmacol 23. https://doi.org/10.1358/mf.2001.23.10.67711810.1358/mf.2001.23.10.677118 ↗
45. Kahle M, Kleber M, Jahn R (2002) Review of XRD-based quantitative analyses of clay minerals in soils: the suitability of mineral intensity factors. Geo 109. https://doi.org/10.1016/S0016-7061(02)00175-110.1016/S0016-7061(02)00175-1 ↗
46. Khan OF, Zaia EW, Jhunjhunwala S, et al (2015) Dendrimer-inspired nanomaterials for the in vivo delivery of siRNA to lung vasculature. Nano Lett 15. https://doi.org/10.1021/nl504897210.1021/nl5048972 ↗
47. Kou L, Bhutia YD, Yao Q, et al (2018) Transporter-guided delivery of nanoparticles to improve drug permeation across cellular barriers and drug exposure to selective cell types. Front Pharmacol 910.3389/fphar.2018.00027 ↗
48. L. G, A. S, K. P (2019) Comparative outcomes of CFTR therapy in pediatric cystic fibrosis. Pediatr Pulmonol 54
49. Lai SK, Wang YY, Wirtz D, Hanes J (2009) Micro- and macrorheology of mucus. Adv Drug Deliv Rev 6110.1016/j.addr.2008.09.012 ↗
50. Langer K, Balthasar S, Vogel V, et al (2003) Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 257. https://doi.org/10.1016/S0378-5173(03)00134-010.1016/S0378-5173(03)00134-0 ↗
51. Laselva O, Conese M (2021) Three-dimensional airway spheroids and organoids for cystic fibrosis research. J Respir 1. https://doi.org/10.3390/jor104002210.3390/jor1040022 ↗
52. Lee JA, Cho A, Huang EN, et al (2021) Gene therapy for cystic fibrosis: new tools for precision medicine. J Transl Med 1910.1186/s12967-021-03099-4 ↗
53. Li B, He W, Ye L, et al (2019) Targeted delivery of sildenafil for inhibiting pulmonary vascular remodeling. Hypertension 73. https://doi.org/10.1161/HYPERTENSIONAHA.118.1193210.1161/HYPERTENSIONAHA.118.11932 ↗
54. Li D, Schneider-Futschik EK (2023) Current and emerging inhaled antibiotics for chronic pulmonary Pseudomonas aeruginosa and Staphylococcus aureus infections in cystic fibrosis. Antibiotics 1210.3390/antibiotics12030484 ↗
55. Li HY, Xu EY (2017) Innovative pMDI formulations of spray-dried nanoparticles for efficient pulmonary drug delivery. Int J Pharm 530. https://doi.org/10.1016/j.ijpharm.2017.07.04010.1016/j.ijpharm.2017.07.040 ↗
56. Li T, Senesi AJ, Lee B (2016) Small angle X-ray scattering for nanoparticle research. Chem Rev 11610.1021/acs.chemrev.5b00690 ↗
57. Liu Y, Yang B, Zhao X, et al (2019) E-selectin-binding peptide–modified bovine serum albumin nanoparticles for the treatment of acute lung injury. AAPS PharmSciTech 20. https://doi.org/10.1208/s12249-019-1403-210.1208/s12249-019-1403-2 ↗
58. Long X, Ren J, Zhang C, et al (2019) Facile and controllable fabrication of protein-only nanoparticles through photo-induced crosslinking of albumin and their application as dox carriers. Nanomaterials 9. https://doi.org/10.3390/nano905079710.3390/nano9050797 ↗
59. Lopes-Pacheco M (2016) CFTR modulators: shedding light on precision medicine for cystic fibrosis. Front Pharmacol 710.3389/fphar.2016.00275 ↗
60. Madhavi V, Reddy AVB, Chennuri BK (2024) Insights into nanocomposite materials for gas sorption applications. Nano-Structures and Nano-Objects 3810.1016/j.nanoso.2024.101127 ↗
61. Marante T, Viegas C, Duarte I, et al (2020) An overview on spray-drying of protein-loaded PNPs for dry powder inhalation. Pharm 12. https://doi.org/10.3390/pharmaceutics1211103210.3390/pharmaceutics12111032 ↗
62. Markowicz-Piasecka M, Mikiciuk-Olasik E (2016) Dendrimers in drug delivery. In: Nanobiomaterials in drug delivery: applications of nanobiomaterials10.1016/B978-0-323-42866-8.00002-2 ↗
63. Menon JU, Ravikumar P, Pise A, et al (2014) PNPs for pulmonary protein and DNA delivery. Acta Biomater 10. https://doi.org/10.1016/j.actbio.2014.01.03310.1016/j.actbio.2014.01.033 ↗
64. Minuti AE, Labusca L, Herea DD, et al (2023) A simple protocol for sample preparation for scanning electron microscopic imaging allows quick screening of nanomaterials adhering to cell surface. Int J Mol Sci 24. https://doi.org/10.3390/ijms2401043010.3390/ijms24010430 ↗
65. Mourdikoudis S, Pallares RM, Thanh NTK (2018) Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. Nanoscale 1010.1039/C8NR02278J ↗
66. Mugabe C, Azghani AO, Omri A (2005) Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 55. https://doi.org/10.1093/jac/dkh51810.1093/jac/dkh518 ↗
67. Muhoza B, Yuyang H, Uriho A, et al (2023) Spray-and freeze-drying of microcapsules prepared by complex coacervation method: a review. Food Hydrocoll 14010.1016/j.foodhyd.2023.108650 ↗
68. Mulhall P, Criner G (2016) Non-pharmacological treatments for COPD. Respirology 2110.1111/resp.12782 ↗
69. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 5010.1016/S0939-6411(00)00087-4 ↗
70. Murgia X, Loretz B, Hartwig O, et al (2018) The role of mucus on drug transport and its potential to affect therapeutic outcomes. Adv Drug Deliv Rev 12410.1016/j.addr.2017.10.009 ↗
71. Ndebele RT, Yao Q, Shi YN, et al (2022) Progress in the application of nano- and micro-based drug delivery systems in pulmonary drug delivery. BIO Integration 310.15212/bioi-2021-0028 ↗
72. Nowak JK, Sobkowiak P, Drzymała-Czyż S, et al (2021) Fat-soluble vitamin supplementation using liposomes, cyclodextrins, or medium-chain triglycerides in cystic fibrosis: a randomized controlled trial. Nutrients 13. https://doi.org/10.3390/nu1312455410.3390/nu13124554 ↗
73. Oliveira AM, Guimarães KL, Cerize NNP, et al (2013) Nano spray drying as an innovative technology for encapsulating hydrophilic active pharmaceutical ingredients (API). J Nanomed Nanotechnol 4. https://doi.org/10.4172/2157-7439.100018610.4172/2157-7439.1000186 ↗
74. Pangua C, Espuelas S, Martínez-Ohárriz MC, et al (2024) Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: application to bevacizumab. Drug Deliv Transl Res 14. https://doi.org/10.1007/s13346-023-01454-010.1007/s13346-023-01454-0 ↗
75. Patel RP, Patel MP, Suthar AM (2009) Spray drying technology: an overview. Indian J Sci Technol 2. https://doi.org/10.17485/ijst/2009/v2i10.310.17485/ijst/2009/v2i10.3 ↗
76. Patil JS, Sarasija S (2012) Pulmonary drug delivery strategies: a concise, systematic review. Lung India 2910.4103/0970-2113.92361 ↗
77. Plaunt AJ, Nguyen TL, Corboz MR, et al (2022) Strategies to overcome biological barriers associated with pulmonary drug delivery. Pharmaceutics 1410.3390/pharmaceutics14020302 ↗
78. Puri R, Sharma A, Sharma S, Arora V (2023) Albumin for application in drug delivery system for lung diseases. In: Natural polymeric materials based drug delivery systems in lung diseases10.1007/978-981-19-7656-8_12 ↗
79. Rahman Sabuj MZ, Islam N (2021) Inhaled antibiotic-loaded PNPs for the management of lower respiratory tract infections. Nanoscale Adv 310.1039/D1NA00205H ↗
80. Ramallo-López JM, Giovanetti L, Craievich AF, et al (2007) XAFS, SAXS and HREM characterization of Pd nanoparticles capped with n-alkyl thiol molecules. Physica B Condens Matter 389. https://doi.org/10.1016/j.physb.2006.07.04410.1016/j.physb.2006.07.044 ↗
81. Raval N, Maheshwari R, Kalyane D, et al (2018) Importance of physicochemical characterization of nanoparticles in pharmaceutical product development. In: Basic Fundamentals of Drug Delivery10.1016/B978-0-12-817909-3.00010-8 ↗
82. Rong A, Han Z, Wang T, et al (2024) Pulmonary delivery of nano-particles for lung cancer diagnosis and therapy: recent advances and future prospects. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1610.1002/wnan.1933 ↗
83. Sadtler V, M. J, Marie E (2012) Low energy emulsification methods for nanoparticles synthesis. In: The delivery of nanoparticles10.5772/35087 ↗
84. Sarker SD, Nahar L (2022) Characterization of nanoparticles. In: Advances in nanotechnology-based drug delivery systems10.1016/B978-0-323-88450-1.00011-9 ↗
85. Saxena J, Bisen M, Misra A, et al (2022) Targeting COPD with PLGA-based nanoparticles: current status and prospects. Biomed Res Int 202210.1155/2022/5058121 ↗
86. Shaikh S, Nazim S, Khan T, et al (2010) Recent advances in pulmonary drug delivery system : a review. Int J App Pharm 2
87. Shilpi S, Vimal VD, Soni V (2015) Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung. Prog Biomater 4. https://doi.org/10.1007/s40204-015-0037-z10.1007/s40204-015-0037-z ↗
88. Sun J, Cheng Y, Zhang T, Zang J (2022) Microencapsulation of carvacrol by complex coacervation of walnut meal protein isolate and gum arabic: preparation, characterization and bio-functional activity. Foods 11. https://doi.org/10.3390/foods1121338210.3390/foods11213382 ↗
89. Truong-Le VL, Thomas August J, Leong KW (1998) Controlled gene delivery by DNA-gelatin nanospheres. Hum Gene Ther 9. https://doi.org/10.1089/hum.1998.9.12-170910.1089/hum.1998.9.12-1709 ↗
90. Unnikrishnan G, Joy A, Megha M, et al (2023) Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review. Discover Nano 1810.1186/s11671-023-03943-0 ↗
91. Wang J, Jansen JA, Yang F (2019) Electrospraying: possibilities and challenges of engineering carriers for biomedical applications - a mini review. Front Chem 710.3389/fchem.2019.00258 ↗
92. Wang Z, Yu F, Hu F (2024) Functional chitosan and its derivative-related drug delivery systems for nano-therapy: recent advances. Pharmaceutics 1610.3390/pharmaceutics16030337 ↗
93. Weber C, Coester C, Kreuter J, Langer K (2000) Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm 194. https://doi.org/10.1016/S0378-5173(99)00370-110.1016/S0378-5173(99)00370-1 ↗
94. Woods A, Patel A, Spina D, et al (2015) In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery. J Control Release 210. https://doi.org/10.1016/j.jconrel.2015.05.26910.1016/j.jconrel.2015.05.269 ↗
95. Yang W, Peters JI, Williams RO (2008) Inhaled nanoparticles-a current review. Int J Pharm 35610.1016/j.ijpharm.2008.02.011 ↗
96. Yue P, Zhou W, Huang G, et al (2022) Nanocrystals based pulmonary inhalation delivery system: advance and challenge. Drug Deliv 29. https://doi.org/10.1080/10717544.2022.203980910.1080/10717544.2022.2039809 ↗
97. Zimmermann CM, Baldassi D, Chan K, et al (2022) Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery. J Control Release 351. https://doi.org/10.1016/j.jconrel.2022.09.02110.1016/j.jconrel.2022.09.021 ↗
98. Al-Nemrawi NK, Alshraiedeh NH, Zayed AL, Altaani BM (2018) Low molecular weight chitosan-coated PLGA nanoparticles for pulmonary delivery of tobramycin for cystic fibrosis. Pharmaceuticals 11. https://doi.org/10.3390/ph1101002810.3390/ph11010028 ↗
99. Elzoghby AO, Samy WM, Elgindy NA (2012) Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 15710.1016/j.jconrel.2011.07.031 ↗
100. Fithrotunnisa Q, Arsianti A, Kurniawan G, et al (2020) In vitro cytotoxicity of Hibiscus sabdariffa Linn extracts on A549 lung cancer cell line. Pharmacogn J 12. https://doi.org/10.5530/pj.2020.12.310.5530/pj.2020.12.3 ↗